These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3743342)

  • 1. [Circulating immune complex (CIC) and antitumor antibody in the serum of rats with thyroid carcinoma induced by 132I].
    Hou JC
    Zhonghua Zhong Liu Za Zhi; 1986 May; 8(3):173-5. PubMed ID: 3743342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulins (Ig) in circulating immune complexes (CIC) in cancer and inflammatory bowel disease (IBD).
    Shafir M; Martinelli G; Bekesi JG; Jaramillo S; Heimann T; Aufses AH
    Eur J Surg Oncol; 1986 Dec; 12(4):351-7. PubMed ID: 3780988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial circulating immune complex levels and mitogen responses during progressive tumor growth in WF rats.
    Rodrick ML; Steele G; Ross DS; Lahey SJ; Deasy JM; Rayner AA; Harte PJ; Wilson RE; Munroe AE; King VP
    J Natl Cancer Inst; 1983 Jun; 70(6):1113-8. PubMed ID: 6602239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of polyethylene glycol precipitable circulating immune complex from carcinoma of cervix patients.
    Das S
    Arch Geschwulstforsch; 1987; 57(4):283-6. PubMed ID: 3675140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of breast carcinoma-associated antigens as a monitor of tumor burden: characterization by monoclonal antibodies.
    Salinas FA; Wee KH; Ceriani RL
    Cancer Res; 1987 Feb; 47(3):907-13. PubMed ID: 3802085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of circulating immune complexes in pulmonary tuberculosis.
    Samuel AM; Ashtekar MD; Ganatra RD
    Clin Exp Immunol; 1984 Nov; 58(2):317-24. PubMed ID: 6437714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on late effects of radioiodine on rats.
    Liu ZH; Fu CS; Li ZK; Chi YC; Song YF; Gao FM; Liu XT; Wei LX
    Sci Sin B; 1986 Oct; 29(10):1039-53. PubMed ID: 3576174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of circulating immune complexes in leprosy.
    Ramos GS; Bottasso OA; Morini JC; Segal-Eiras A
    Rev Argent Microbiol; 1988; 20(4):163-70. PubMed ID: 3247413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Circulating immune complexes in breast cancer].
    Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
    Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility and monitoring of breast cancer by circulating immune complexes.
    Dass TK; Aziz M; Rattan A; Tyagi SP
    Indian J Pathol Microbiol; 1992 Oct; 35(4):298-307. PubMed ID: 1344219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of circulating immune complexes in malignant tumours of head and neck.
    Das TK; Aziz M; Rattan A; Sherwani R
    J Indian Med Assoc; 1995 Jan; 93(1):3-7. PubMed ID: 7759908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the presence of circulating immune complexes and their relationship to glomerular IgG deposits in streptozotocin-induced diabetic rats.
    Abrass CK
    Clin Exp Immunol; 1984 Jul; 57(1):17-24. PubMed ID: 6378460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Carcinogenic effects of 131I and 132I observed in the thyroid glands of rats (author's transl)].
    Liu ZH
    Zhonghua Yi Xue Za Zhi; 1981 Oct; 61(10):610-2. PubMed ID: 6800602
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of circulating immune complexes in prognostic evaluation and management of genitourinary cancer patients.
    Aziz M; Das TK; Rattan A
    Indian J Cancer; 1997 Sep; 34(3):111-20. PubMed ID: 9491672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of two antigen nonspecific assays for circulating immune complexes using a model system.
    Rodrick M; Rayner A; Steele G; Harte P; Finn D; Verhave M; Munroe A; Zamcheck N; Wilson R
    J Clin Lab Immunol; 1982 Apr; 7(3):193-8. PubMed ID: 6178827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathologic observations on the carcinogenic effects of 131I, 132I and 125I in the thyroid of rats].
    Liu ZH
    Zhonghua Yi Xue Za Zhi; 1985 Jul; 65(7):400-3, 446. PubMed ID: 3938323
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasia.
    Lahey SJ; Steele G; Berkowitz R; Rodrick ML; Ross DS; Goldstein DP; Zamcheck N; Wilson RE; Deasy JM
    J Natl Cancer Inst; 1984 May; 72(5):983-90. PubMed ID: 6325794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 131I and 132I carcinogenic effects in rat thyroid glands.
    Liu ZH; Fu CS; Li CM; Zhang ZX; Zhang TB; Piao CQ; Chang CL; Huo LM; Wei LX
    Chin Med J (Engl); 1982 Sep; 95(9):641-8. PubMed ID: 6817987
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxicology and Carcinogenesis Studies of C.I. Pigment Red 3 (CAS No. 2425-85-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1992 Mar; 407():1-289. PubMed ID: 12621523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of 2,2-Bis(Bromomethyl)-1,3-Propanediol (FR-1138(R)) (CAS No. 3296-90-0) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 May; 452():1-465. PubMed ID: 12594523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.